Abstract
ASSAY and Drug Development TechnologiesVol. 2, No. 1 ProfileAn Interview with Stephen Michnick, Ph.D., Associate Professor, Department of Biochemistry, University of MontrealVicki GlaserVicki GlaserSearch for more papers by this authorPublished Online:5 Jul 2004https://doi.org/10.1089/154065804322966261AboutSectionsPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail FiguresReferencesRelatedDetailsCited byLabel-free kinetic binding data as a decisive element in drug discovery18 October 2006 | Expert Opinion on Drug Discovery, Vol. 1, No. 5Replacing affinity with binding kinetics in QSAR studies resolves otherwise confounded effects1 January 2007 | Journal of Chemometrics, Vol. 20, No. 8-10 Volume 2Issue 1Feb 2004 To cite this article:Vicki Glaser.An Interview with Stephen Michnick, Ph.D., Associate Professor, Department of Biochemistry, University of Montreal.ASSAY and Drug Development Technologies.Feb 2004.1-6.http://doi.org/10.1089/154065804322966261Published in Volume: 2 Issue 1: July 5, 2004PDF download
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
